中文名稱：兔抗ERBB2多克隆抗體

英文名稱： Anti-ERBB2 rabbit polyclonal antibody

別名： NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu

相關(guān)類別： 一抗

儲(chǔ) 存： 冷凍（-20℃）

宿主： Rabbit

抗原： ERBB2

反應(yīng)種屬： Human, Mouse, Rat

標(biāo) 記物： Unconjugate

克隆類型： rabbit polyclonal

技術(shù)規(guī)格

Background:

The ErbB2 (HER2) proto-oncogene encodes a 185 kDa transmembrane, receptor-like glycoprotein with intrinsic tyrosine kinase activity. While ErbB2 lacks an identified ligand, ErbB2 kinase activity can be activated in the absence of a ligand when overexpressed and through heteromeric associations with other ErbB family members. Amplification of the ErbB2 gene and overexpression of its product are detected in almost 40% of human breast cancers. Binding of the c-Cbl ubiquitin ligase to ErbB2 at Tyr1112 leads to ErbB2 poly-ubiquitination and enhances degradation of this kinase. ErbB2 is a key therapeutic target in the treatment of breast cancer and other carcinomas and targeting the regulation of ErbB2 degradation by the c-Cbl-regulated proteolytic pathway is one potential therapeutic strategy. Phosphorylation of the kinase domain residue Tyr877 of ErbB2 (homologous to Tyr416 of pp60c-Src) may be involved in regulating ErbB2 biological activity. The major autophosphorylation sites in ErbB2 are Tyr1248 and Tyr1221/1222; phosphorylation of these sites couples ErbB2 to the Ras-Raf-MAP kinase signal transduction pathway.

Applications:

ELISA, WB, IHC

Name of antibody:

ERBB2

Immunogen:

Synthetic peptide of human ERBB2

Full name:

erb-b2 receptor tyrosine kinase 2

Synonyms:

NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu

SwissProt:

P04626

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human brain and human ovarian cancer

IHC Recommend dilution:

20-100

WB Predicted band size:

138 kDa

WB Positive control:

231 and Hela cell lysates

WB Recommended dilution:

200-1000

展開全部

兔抗ERBB2多克隆抗體說明書
下載

欧美一级免费-欧美一级免费观看-欧美一级免费看-欧美一级免费片-jizzjizz大全-jizzjizz国产精品

021-54845833/15800441009

ELISA試劑盒

PCR試劑盒

生化試劑盒

細(xì)胞系

細(xì)胞庫(kù)

基礎(chǔ)培養(yǎng)基

完全培養(yǎng)基

原代細(xì)胞

細(xì)胞專用培養(yǎng)基

菌株

生化試劑

病理染色液

科研抗體

標(biāo)準(zhǔn)品

血清

產(chǎn)品中心

最新產(chǎn)品

相關(guān)文章

兔抗ERBB2多克隆抗體

Background:	The ErbB2 (HER2) proto-oncogene encodes a 185 kDa transmembrane, receptor-like glycoprotein with intrinsic tyrosine kinase activity. While ErbB2 lacks an identified ligand, ErbB2 kinase activity can be activated in the absence of a ligand when overexpressed and through heteromeric associations with other ErbB family members. Amplification of the ErbB2 gene and overexpression of its product are detected in almost 40% of human breast cancers. Binding of the c-Cbl ubiquitin ligase to ErbB2 at Tyr1112 leads to ErbB2 poly-ubiquitination and enhances degradation of this kinase. ErbB2 is a key therapeutic target in the treatment of breast cancer and other carcinomas and targeting the regulation of ErbB2 degradation by the c-Cbl-regulated proteolytic pathway is one potential therapeutic strategy. Phosphorylation of the kinase domain residue Tyr877 of ErbB2 (homologous to Tyr416 of pp60c-Src) may be involved in regulating ErbB2 biological activity. The major autophosphorylation sites in ErbB2 are Tyr1248 and Tyr1221/1222; phosphorylation of these sites couples ErbB2 to the Ras-Raf-MAP kinase signal transduction pathway.
Applications:	ELISA, WB, IHC
Name of antibody:	ERBB2
Immunogen:	Synthetic peptide of human ERBB2
Full name:	erb-b2 receptor tyrosine kinase 2
Synonyms:	NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu
SwissProt:	P04626
ELISA Recommended dilution:	5000-10000
IHC positive control:	Human brain and human ovarian cancer
IHC Recommend dilution:	20-100
WB Predicted band size:	138 kDa
WB Positive control:	231 and Hela cell lysates
WB Recommended dilution:	200-1000